DCGI gives EUA for mRNA-based Omicron-specific booster vaccine from Gennova EP News Bureau Jun 20, 2023 The Omicron specific mRNA vaccine will be available under the name – GEMCOVAC-OM and adults of 18 years of age and older can take…
India’s first homegrown mRNA COVID-19 vaccine currently under final clinical trial stages:… Press Trust of India Feb 11, 2022 The vaccine is being developed by Pune-based Gennova Biopharmaceuticals, informed Dr VK Paul, Member (health), NITI Aayog
mRNA COVID-19 vaccine approvals likely to increase development and approvals in oncology: GlobalData EP News Bureau Jan 29, 2021 Currently, there are 44 ongoing clinical trials exploring mRNA vaccines, of which 48 per cent are for oncology indications, where…
